PBA Offers Site for Patients with sVMA

“As we age, many will start to experience distorted or decreased vision. There can be many reasons for these changes - but one diagnosis in particular may be less well known: symptomatic vitreomacular adhesion (symptomatic VMA), a disease that can occur in people over the age of 50 and primarily in those over 70,” notes the post on EyeWire Today. “In order to educate the public on this condition and new treatment options recently made available, Prevent Blindness America has introduced the sVMA Learning Center to its website, providing the most up-to-date information on the disease, warning signs and treatment options. Located at preventblindness.org/svma, the sVMA Learning Center is the newest addition to PBA’s online educational library that offers credible, comprehensive information on a range of vision-related topics.” Read more.

FDA Approves Drug for VMA

"A new medication, Jetrea (ocriplasmin), has been approved by the FDA for VMA (symptomatic vitreomacular adhesion), an eye condition related to aging that can lead to complications and vision loss. When the vitreous gel adheres too strongly to the retina, it can lead to VMT (vitreomacular traction), which may in the long-run affect vision significantly." That's a new post on Medical News Today. Read more.